JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway

Business by 2FIRSTS
Jun.06.2024
JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway
JSTE Technology Mr. Liu De Wen responds to JFT's creditor letter, claiming it contains falsehoods. The full statement follows.

On June 6th at noon, Mr. Liu Dewen, the head of JSTE Electronic Technology (Dongguan) Co., Ltd., publicly responded to the "Letter to Creditors" released by JFT, stating that the letter contained falsehoods.

 

The complete response is as follows:

 

JFT Company confirmed in a December 2021 email that they had acquired a 50% stake in our JSTE factory, but they suddenly changed their minds in September 2022 and decided to sell their stake instead of acquiring it. They officially exited JSTE in January 2023 and received a significant amount of money from the stock transfer.

During the equity exit process, JFT company confirmed the value of over 60 million worth of JUSTFOG brand e-cigarettes under the original processing agreement, but they have been delaying payment and not taking delivery. After several months of dragging their feet, they suddenly notified of the termination of the processing partnership, leaving Jest in a difficult situation.

 

However, the European agents of JFT company continue to authorize domestic licensed trading companies to request small batches of JUSTFOG branded e-cigarettes for sale. Unfortunately, this led to a criminal charge of trademark infringement by JFT, claiming that the e-cigarettes produced under the original agreement were unauthorized. The malicious intent behind this action is surprising, and this absurdity cannot be justified. Jast company reserves the right to hold the criminal plaintiff accountable for their legal responsibility.

 

Subsequently, Jast Company employed legal methods such as litigation and arbitration to seek compensation, and successfully obtained an injunction to preserve JFT Company’s registered trademarks (such as JUSTFOG) in China, as well as its fully-owned subsidiary’s bank accounts and patents related to the e-cigarette business in China. The breach of contract case is scheduled to be heard in the near future.

 

At the same time, Gest also filed a patent confirmation lawsuit to the court. During the cooperation between both parties, JFT appointed a research and development manager who established a labor relationship with Gest, and transferred numerous patents to its wholly-owned subsidiary, severely infringing on Gest's rights.

 

As a leading media and think tank in the field of atomization technology, 2FIRSTS closely monitors the latest developments on this issue and maintains contact with various parties.


 

Click on the image to read: "Vape Debt Risk: How can the operational difficulties of a single company affect the entire industry chain?"

 

JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway

 

Click on the image to read: JSTE Electronic Technology (Dongguan) Co., Ltd. Announces Liquidation

 

JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway
Click on the image to read: JSTE Electronic Technology (Dongguan) Co., Ltd. Announces Liquidation

 

Click on the image to read: "JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations".

 

JSTE's Response to JFT Regarding Debt Situation: False Allegations, Litigation Underway
Click on the image to read: "JUSTFOG Official Response: JSTE's Liquidation is for Self-Protection after Serious Violations"

 

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor Ron DeSantis announced an expansion of Temporary Assistance for Needy Families (TANF) restrictions that would prohibit Electronic Benefit Transfer (EBT) funds from being used to purchase tobacco and vaping products. The state will amend its TANF State Plan and submit the changes for federal approval. Florida officials said the restrictions would not affect eligibility for temporary cash assistance or the amount of benefits received, but would change how funds can be spent.
Aug.25
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26